Piper Sandler analyst Paul Newsome raised the firm’s price target on ProAssurance (PRA) to $25 from $18 and keeps a Neutral rating on the shares. The firm notes the company reported a miss versus PSC and consensus. Underwriting results were worse than expected, but top-line results were higher than Piper expected and premiums in the company’s medical malpractice business were stable. Bottom-line results were impacted by non-operating items totaling $12.6M related to its merger with The Doctors Company, the firm adds.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRA:
- ProAssurance Reports Q1 2025 Net Loss Amid Acquisition News
- ProAssurance reports Q1 EPS 13c, consensus 20c
- ProAssurance downgraded to Underperform from Market Perform at Raymond James
- ProAssurance downgraded to Market Perform from Outperform at Citizens JMP
- Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz